Alexandra McAleenan

发表

Cost-effectiveness planes: base-case economic evaluation

Peter Bryden, Julian Pt Higgins, Jonathan A C Sterne, 2017 .

RoB 2: a revised tool for assessing risk of bias in randomised trials

Natalie S Blencowe, Christopher J Cates, Isabelle Boutron, 2019, BMJ.

Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net

Leonhard Held, Stephan Harbarth, Stavros Nikolakopoulos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.

Peter Bryden, Nicky J Welton, Gene Feder, 2017, Health technology assessment.